IRD
Opus Genetics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.18
−1.89%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $1.5M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.16
- Revenue actual
- $755.0K
- Revenue estimate
- $2.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +14.5%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $13
- PT range
- $8.00 – $20
- Analysts
- 7
7 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.16 | -$0.14 | Beat 10.64% | $755.0K |
| May 21, 2026 | -$0.16 | -$0.19 | Miss -18.75% | $3.9M |
| Nov 12, 2025 | -$0.14 | -$0.12 | Beat 14.29% | $3.1M |
| Aug 13, 2025 | -$0.25 | -$0.12 | Beat 52.00% | $2.9M |
| May 15, 2025 | -$0.34 | -$0.32 | Beat 5.88% | $4.4M |
| Mar 31, 2025 | -$0.34 | -$1.27 | Miss -273.53% | $4.3M |
| May 10, 2024 | -$0.18 | -$0.29 | Miss -61.11% | $1.7M |
| Mar 8, 2024 | -$0.05 | -$0.22 | Miss -315.20% | $1.7M |
| Nov 13, 2023 | -$0.22 | $0.25 | Beat 211.80% | $11.9M |
| Jun 30, 2023 | -$0.23 | -$0.24 | Miss -4.73% | $3.7M |
| Dec 31, 2022 | — | $1.58 | — | $39.9M |
| Sep 30, 2022 | -$0.28 | -$0.22 | Beat 21.62% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026